Skip to content

Investment Purchases at other companies

Absci Corporation logo
Absci CorporationABSI
$18.61M-53.6%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$50.9M+132%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$222.18M+274%
Arrowhead Research logo
Arrowhead ResearchARWR
$924.64M+43.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$30.37M-29.8%

Other financials

Income statement

See full
Revenue$6.5M-56.1%
Gross profit-$6.0M+15.0%
Operating income-$128.5M+32.8%
Net income-$117.5M+42.0%
EPS (diluted)-$0.22+56.0%

Balance sheet

See full
Cash & equivalents$665.2M+30.6%
Total debt$88.6M-24.6%
Total equity$1.0B+9.7%
Total assets$1.3B+2.6%

Cash flow

See full
Operating cash flow-$81.1M+38.5%
CapEx$258.0K-85.9%
Free cash flow-$81.4M+39.2%

Valuation

See full
Market cap$1.71B-23.7%
Enterprise value$1.14B-39.8%
P/S25.8×-11.8×

Profitability

See full
Gross margin7.2%
Operating margin-881.3%-66.8pp
Net margin-842.9%-92.4pp
FCF margin-490.7%-102pp

Returns & leverage

See full
Return on equity-57.2%-14.4pp
Debt / equity0.1×0.0×
Current ratio5.5×+1.4×

Where this comes from

Reported directly by Recursion Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s investment purchases?
Recursion Pharmaceuticals, Inc. (RXRX) reported investment purchases of $0 in Q1 2026.
How has Recursion Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
Recursion Pharmaceuticals, Inc.'s investment purchases decreased by 100.0% year-over-year, from $1M to $0.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.